TRiCBIO
Models & ProductsNavigation menu
R&D ServicesModels & ProductsApplicationsTechnologyEvidence & ResourcesHow We WorkAbout TRiCBIOProject inquiry中文

Models & products

Choose the right organoid model and study system

Compare tumor PDOs, normal-tissue organoids and disease models by project goal, available assays and collaboration format. Browse options for supplied models, TRiCBIO-run studies and custom development.

Model type
Model offering
Quick comparisons

Start from a common study combination or select up to three models.

Choosing PDO 1.0 or PDO 2.0

7 models shown

0 of 3 models selected for comparison

Matching models

PanCK, CD3 and DAPI profiling in renal tumor tissue and PDO 2.0 across culture time
Model & study servicesALI

Tumor PDO 2.0

An ALI-based tumor model for studying treatment response alongside source-tissue architecture and immune cells retained from the sample.

CD3CD4CD8
DAPI, ER and Ki67 staining in a breast cancer PDO
Model & study servicesPDO 1.0

Breast cancer PDO

Patient-derived breast tumor organoids for single-agent and combination studies, with PDO 2.0 / ALI considered when immune context is relevant.

ERPRKi67
Bright-field morphology of a colorectal cancer PDO
Model & study servicesPDO

Colorectal cancer PDO

Established from primary or metastatic colorectal tumors to compare drug response, tissue features and inter-sample differences.

Epithelial identityH&EDrug response
H&E, CD31 and HEP-1 immunohistochemistry in HCC source tissue and PDO
Model & study servicesPDO

HCC PDO / PDO 2.0

Use conventional PDOs for HCC efficacy studies. Immunotherapy or anti-angiogenic programs can add PDO 2.0, vascular-marker profiling or a purpose-built co-culture.

AlbuminCK19CD8
RCC source-tissue H&E, PDO bright-field and PDO H&E comparison
Model & study servicesPDO

Renal cancer PDO

A renal cancer PDO system for evaluating responses to targeted and immune therapies using apoptosis and immune-cell activation readouts.

PAX8CD10CD3
PDAC source tissue, PDO bright-field, PDO histology and CK19/CD3 immunofluorescence
Model & study servicesPDO

Pancreatic cancer PDO

Use conventional PDOs for pancreatic epithelial and drug-response studies, with ALI or custom co-culture added when stromal or immune context is important.

CK19CD3CD8
Two GIST morphology groups comparing tissue-derived cultures, source-tissue H&E and culture H&E
Tailored studiesCustom 3D culture

Mesenchymal tumor PDO

Case-specific model development, phenotype profiling and candidate-response studies for GIST, osteosarcoma and related tumors.

Pathology-definedMutation-definedProtein markers

PRODUCT CATALOG

Organoid products & reagents

5 products & familiesYour quotation confirms the configuration, packaging, lead time and accompanying documents.
Choose the right level of support

Purchase a configured product, add technical guidance for setup, or commission TRiCBIO to run the study.